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Abstract
Surfactant proteins B and C (SP-B and SP-C), together with phospholipids, are important constituents of pulmonary
surfactant and of preparations used for treatment of respiratory distress syndrome (RDS). SP-B belongs to the saposin
family of homologous proteins, which include other lipid-interacting proteins, like the membranolytic NK-lysin. SP-B, in
contrast to other saposins, is hydrophobic and a disulfide-linked dimer, and its mechanism of action is not known. A model
of the three-dimensional structure of one SP-B subunit was generated from the structure of monomeric NK-lysin determined
by nuclear magnetic resonance, and the SP-B dimer was formed by joining two subunits via the intersubunit disulfide bond
Cys48^Cys48P. After energy minimization, intersubunit hydrogen bonds/ion pairs were formed between the strictly conserved
residues Glu51 and Arg52, which creates a central non-polar region located in between two clusters of positively charged
residues. The structural features support a function of SP-B in cross-linking of lipid membranes. Mixtures of phospholipids,
an SP-C analogue and polymyxin B (which cross-links lipid vesicles but is structurally unrelated to SP-B) exhibit in vitro
surface activity which is indistinguishable from that of analogous mixtures containing SP-B instead of polymyxin B. This
suggests an avenue for identification of SP-B analogues that can be used in synthetic surfactants for treatment of
RDS. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Pulmonary surfactant contains about 80 weight %
phospholipids, 10% neutral lipids and 10% proteins.
Four surfactant proteins (SPs) have been character-
ized, namely SP-A, SP-B, SP-C and SP-D [1]. SP-B,
which constitutes approximately 0.5^1 weight % of
pulmonary surfactant, is the only protein for which
there is ¢rm evidence for an essential function in
respiration. Human hereditary de¢ciency of SP-B
causes severe respiratory distress soon after birth
[2] and SP-B null mice likewise exhibit fatal respira-
tory dysfunction [3]. In contrast, SP-A knock-out
mice do not show signs of respiratory malfunction,
but are more susceptible to bacterial infections than
wild-type mice [4], and SP-D knock-out mice exhibit
disturbed surfactant homeostasis but no apparent
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respiratory dysfunction [5,6]. SP-B and SP-C are
present in natural surfactant preparations used for
treatment of respiratory distress syndrome (RDS)
in premature infants. The use of animal lungs for
production of natural surfactants is disadvantageous
in several respects, and the identi¢cation of ana-
logues of SP-B and SP-C would be of signi¢cant
value.
SP-B is a 17.4 kDa homodimeric protein. Each 79
residue polypeptide chain contains three disul¢des
and the dimer is held together by a disul¢de bond
linking Cys48 of the two subunits [1]. The SP-B poly-
peptide chain exhibits about 20^25% pairwise se-
quence identity, including identical location of the
half-cystines that form intrachain disul¢des, to a
group of other proteins, now referred to as the sap-
osin family, which include sphingolipid activating
proteins (saposins) A, B, C and D, amoebapores,
NK-lysin and parts of lipid-metabolizing enzymes
[7]. This indicates that these proteins are structural
homologues. However, among the saposins, SP-B is
the only protein which is a covalent dimer and which
is hydrophobic. The dimeric structure of SP-B may
be functionally important, e.g. by making it possible
to cross-link di¡erent lipid membranes, see [1].
It can be anticipated that the size and hydropho-
bicity of SP-B will make it di⁄cult to experimentally
determine its three-dimensional structure in the near
future. The three-dimensional structure of mono-
meric NK-lysin in water was recently determined
by nuclear magnetic resonance (NMR) methods,
but does not unambiguously reveal NK-lysin’s
mode of interaction with lipid membranes [8,9]. We
have generated an SP-B model based upon the NK-
lysin NMR structure and evaluated di¡erent modes
of SP-B membrane interactions. The model structure
agrees with a function of SP-B in vesicle cross-link-
ing, and surface activity experiments show that poly-
myxin B, a naturally occurring acylpeptide which
cross-links lipid vesicles [10,11], can work as an SP-
B analogue in vitro.
2. Materials and methods
2.1. Model building
A three-dimensional model of porcine SP-B was
obtained by adopting its amino acid sequence into
the known fold of NK-lysin (PDB code 1NKL; [8])
using the program ICM (version 2.7, Molsoft LLC,
Metuchen, NJ, USA, 1998). SP-B residues 5^22,
23^40, 42^79 were aligned against NK-lysin residues
1^18, 23^40, 41^78, respectively, and disul¢de bonds
Cys8^Cys77, Cys11^Cys71 and Cys35^Cys46 were
introduced. First, the tethers imposed between the
corresponding residues of the two proteins were
minimized. The structure was then optimized using
the biased Monte-Carlo technique [12] with an initial
series of 198 000 steps at 300 K. The loop region
between Ala20 and Gly25 of SP-B, which is not
present in NK-lysin, was then further minimized
with 20 000 steps at 1500 K. Finally, the Monte-Car-
lo procedure was repeated for the whole structure
with 201 000 steps at 1500 K and subsequently for
the region Ala20^Gly25 with 200 000 steps at 1500
K.
To build the SP-B dimer, a disul¢de bond was
introduced between the Cys48 residues of each sub-
unit. The dimer was then subjected to a series of
1 000 000 Monte-Carlo energy minimizations at 700
K with the program ICM. During this calculation,
the polypeptide backbone was kept ¢xed, while all
bonds of the side-chains were free. These calculations
were repeated six times, each time starting with a
di¡erent relative orientation of the two subunits, in
order not to bias the result by the initial conforma-
tion. Finally, the dimeric structure with lowest calcu-
lated energy was used in the further analyses.
2.2. Surface activity measurements
Peptide lipid mixtures were obtained by combin-
ing, in chloroform/methanol, dipalmitoylphosphati-
dylcholine (DPPC), phosphatidylglycerol (PG), 3%
(w/w) of a synthetic analogue of SP-C (SP-C(LKS),
[13]) and, in some samples, 2% (w/w) of porcine SP-B
[14]. The organic solvents were evaporated and the
peptide lipid ¢lm was hydrated in 10 mmol/l HEPES
bu¡er (pH 6.9) containing 140 mmol/l NaCl and
2 mmol/l CaCl2 at a lipid concentration of 10 mg/
ml. In the samples where SP-B was substituted with
polymyxin B, 1% (w/w) of polymyxin B sulfate (Sig-
ma) was added to the HEPES bu¡er. The peptide
mass proportions are similar to those of SP-B and
SP-C in pulmonary surfactant [1]. Surface tension of
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the mixtures was determined in a pulsating bubble
surfactometer [15] at minimum (Qmin) and maximum
(Qmax) bubble radius. After 2 min equilibration at
maximum bubble radius, the recordings were ob-
tained at 37‡C and approximately 50% surface com-
pression at a rate of 40 cycles per min.
3. Results and discussion
3.1. Generation of a structural model of SP-B
The amino acid sequence of porcine SP-B was
modelled into the fold of porcine NK-lysin known
from NMR spectroscopy [8], according to the align-
ment of the SP-B and NK-lysin amino acid sequen-
ces used for prediction of secondary structure ele-
ments [7]. The results show that the NK-lysin fold
can accommodate the SP-B amino acid sequence
without major structural rearrangements, which sup-
ports the prediction from sequence alignments that
these proteins are structurally homologous [7]. Fur-
ther support for the validity of the SP-B model
comes from the fact that the variable positions in
the SP-B amino acid sequence, as deduced from
alignment of known species variants (Fig. 1), are
predominantly located at the surface of the molecule,
while the non-polar residues that are conserved in the
saposins [7,8] constitute the core of the protein.
A model of the SP-B dimer was generated by join-
ing two SP-B subunits via the intersubunit Cys48^
Cys48P disul¢de bond, and subjecting the dimer to
energy minimization. In the calculated conforma-
tions with lowest energy, the Glu51^Arg52 dipeptide
segments of the two di¡erent subunits are located in
the subunit interface (Fig. 2). The location is such
that they can form two intersubunit ion pairs/hydro-
gen bonds, i.e. one between Glu51 and Arg52P and
the other between Glu51P and Arg52 (Fig. 3). SP-B
molecules with these ion pairs/hydrogen bonds con-
sistently showed lower energy values than models
where they did not form. Furthermore, the ion
pairs/hydrogen bonds were formed also when the
Glu51^Arg52 dipeptide segments of each subunit
were located at maximum distance in the starting
conformation before the Monte-Carlo procedure.
This suggests that these two intersubunit ion pairs/
hydrogen bonds are formed in native SP-B. Support
for this conclusion comes from the fact that the
Glu51^Arg52 dipeptide segment is strictly conserved
in all SP-B sequences known (Fig. 1), but is lacking
in all the monomeric saposins. Notably, Glu51 is the
only acidic residue that is strictly conserved in SP-B.
However, it should be pointed out that the values of
the energy di¡erences between structures with and
without the ion pairs/hydrogen bonds are small and
that therefore the SP-B dimer can be stabilized solely
from interactions between neutral residues and the
intersubunit disul¢de bond (see further below).
The intersubunit Glu51^Arg52P/Glu51P^Arg52 ion
pairs/hydrogen bonds lock the dimer interface into a
¢xed position. Dimeric SP-B is an elongated mole-
cule with approximate dimensions of 55U37 Aî (Fig.
3), and a subunit interface area of about 800 Aî 2. The
global distribution of charged and hydrophobic res-
idues in the SP-B model is visualized in Fig. 3. The
nine positive and two negative charges per subunit
are clustered in two regions located at the opposite
poles of SP-B and separated by approximately 33 Aî .
The region between the charged clusters consists
mainly of residues with non-polar side-chains, except
for the Glu51^Arg52 dipeptide segment (Fig. 3). For-
mation of the Glu51^Arg52P/Glu51P^Arg52 hydro-
gen bonds/ion pairs can however neutralize these
charges (see further below). The residue at position
59, which is acidic in all investigated species except
pig (Fig. 1), is super¢cially located and lies outside
the non-polar region.
Fig. 1. Alignment of SP-B species variants. Alignment of SP-B amino acid sequences from species where the complete primary struc-
ture is established. Positions where the residues are not identical in all species are given against a gray background.
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3.2. The SP-B model structure in lipid membranes
How SP-B interacts with lipid membranes is not
understood in detail, and several di¡erent predictions
of the location of the SP-B in a phospholipid envi-
ronment have been put forward [1,16,17]. Clearly,
the large non-polar parts of SP-B (Fig. 3) need to
interact with a non-polar environment. It is widely
held from several experimental studies that SP-B
lacks transmembrane segments and is associated
with super¢cial parts of lipid membranes, mainly be-
cause only limited e¡ects on the ordering of the lipid
acyl-chains have been observed, while the lipid head-
groups are a¡ected to a signi¢cant extent by SP-B
[18^20]. More precisely, at low SP-B content and
with gel-phase lipids, little e¡ect on acyl-chain order
can be detected, while at higher SP-B contents and
with £uid phase lipids, e¡ects on acyl-chain ordering,
although still modest, can be detected [21,22]. It has
been concluded that SP-B can interact with the edges
of lipid bilayer discs and also induce disc formation,
see [23]. The model structure is fully compatible with
such an interaction; the positively charged poles of
SP-B could interact with the phospholipid head-
groups, and the non-polar part could interact with
the acyl-chains (Fig. 4A). Likewise, SP-B situated in
the super¢cial parts of a lipid bilayer would bury the
non-polar part in the membrane acyl-chains and lo-
calize the positive clusters close to the phospholipid
head-groups (Fig. 4B). SP-B located at the edges of
lipid bilayer discs or in the super¢cial region is com-
patible both with current experimental data and the
main features of the structural model.
In contrast to the situations where SP-B is located
at lipid disc edges or in the super¢cial parts of a
bilayer, the lack of experimental support for a trans-
membrane orientation of SP-B is not possible to ra-
tionalize in a straightforward manner from the mod-
el. Naively, the model structure is possible to
accommodate in a transmembrane manner in a phos-
Fig. 2. Close-up of the subunit interface. Helix three of each subunit with the Cys48^Cys48P disul¢de, and the Glu51^Arg52P/Glu51P^
Arg52 hydrogen bonds/ion pairs are shown. The dotted lines represent the hydrogen bonds formed between a Glu carboxyl oxygen
and the Arg guanidinium group.
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pholipid bilayer. In the SP-B model, there is a dis-
tance of 33^40 Aî between the clusters of positively
charged residues (Fig. 3), which is in good agreement
with the distance between the polar phospholipid
head-group regions of a £uid DPPC (the main con-
stituent of surfactant) membrane, about 37 Aî [24]. A
transmembrane orientation would locate the Glu51^
Arg52 segments in the acyl-chain part (Fig. 4C). In a
lipid environment, formation of the Glu51^Arg52P/
Glu51P^Arg52 intersubunit ion pairs/hydrogen bonds
is expected to be favored over the exposure of
charged side-chains. Vandenbussche and coworkers
[19] concluded from dichroic infrared spectra of
SP-B in phospholipid membranes that 60^80% of
the SP-B K-helices are parallel to the acyl-chains.
With a transmembraneous insertion of the SP-B
model, 50^60% of the helical residues would assume
an orientation parallel to the acyl-chains. Further-
more, the most likely orientation of NK-lysin in lipid
membranes from all available data [9] is similar to
the orientation that each SP-B subunit will assume if
the dimer is situated in a transmembraneous manner.
From the model data, it is not possible to identify
one preferred orientation of SP-B in a lipid mem-
brane. Perhaps, the apparent versatility of the SP-
B/lipid interactions (Fig. 4) re£ects a dynamic behav-
ior of the protein in a membrane environment.
3.3. The cross-linking peptide polymyxin B mimics the
surface activity of SP-B in vitro
SP-B can fuse membranes, in particular in the
presence of anionic phospholipids [25^28], and it
has been suggested that SP-B can act by cross-linking
two phospholipid bilayers, or a phospholipid bilayer
and a phospholipid monolayer [1,13,29,30]. In line
with this, the addition of SP-B to lipid/SP-C ana-
logue mixtures lowers the surface tension at maxi-
mum radius in a pulsating bubble surfactometer,
which was suggested to be an e¡ect of SP-B binding
Table 1
Functional similarity between polymyxin B and SP-B
Peptide content (weight %) Surface tension (mN/m)
SP-C(LKS) SP-B Polymyxin B 7.5 s 1 min 5 min
Qmin Qmax Qmin Qmax Qmin Qmax
3 ^ ^ 15 (3) 39 (4) 16 (2) 42 (3) 13 (3) 44 (3)
3 2 ^ 2 (2) 26 (3) 1 (1) 29 (3) 6 1 35 (1)
3 ^ 1 3 (2) 29 (3) 2 (2) 31 (3) 1 (1) 34 (2)
The preparations were composed of DPPC/PG (7:3, w/w) and the indicated amounts of an SP-C analogue (SP-C(LKS), SP-B or poly-
myxin B. The mixtures were examined at a concentration of 10 mg/ml in 10 mmol/l HEPES bu¡er (pH 6.9) containing 140 mmol/l
NaCl and 2 mmol/l CaCl2. The recordings were obtained with a pulsating bubble surfactometer at 37‡C and 50% surface compression
at a rate of 40 per min. The values are the mean (S.D.) of 3^20 measurements.
Fig. 3. Polarity of the surface of SP-B. Skin representation of
the SP-B dimer where charged residues (Lys, Arg, His, Glu,
Asp) are colored blue and hydrophobic residues (Cys, Met,
Leu, Ile, Val, Trp, Phe) colored yellow. Other residues are in
white. The ¢gure was made with the program ICM.
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subphase lipid vesicles close to the air/liquid interface
[13].
In order to test experimentally whether the postu-
lated cross-linking ability of SP-B is relevant for its
surface activity, we compared the e¡ects of SP-B
with those of polymyxin B, an acylated cyclic cati-
onic nonapeptide which cross-links phospholipid
vesicles by ionic interactions and promotes interve-
sicle lipid transfer [10,11]. Addition of 1% (w/w) of
polymyxin B to vesicles composed of DPPC/PG/SP-
C analogue gives practically identical reduction of
Qmin and Qmax in a pulsating bubble surfactometer
as the addition of 2% (w/w) SP-B (Table 1). Higher
amounts of polymyxin B did not yield further reduc-
tion in surface tension. Polymyxin B has been sug-
gested to act as a hexamer [10], and the molar ratio
of SP-B and polymyxin B hexamers in the surfactant
preparations studied is 0.7. This experiment suggests
that the function of SP-B to a signi¢cant extent de-
pends on cross-linking of lipid vesicles, and can be
mimicked by a simpler peptide.
The SP-B model lends structural support to cross-
linking properties of SP-B. Fig. 5 depicts how SP-B
could cross-link two membranes and a¡ord a non-
polar surface for intermembrane lipid transfer. It ap-
pears possible that this arrangement can be reached
both from a start situation where SP-B is in a trans-
membraneous orientation, and from a situation
where SP-B is initially super¢cially located in a phos-
pholipid bilayer (Fig. 4). Membrane cross-linking
and/or fusion probably occur during several steps
of the pulmonary surfactant life cycle. For example,
transformations from lamellar bodies to tubular
myelin and from tubular myelin to an interfacial sur-
face active lipid layer likely involve membrane cross-
linking [31].
Previously published SP-B analogues have been
considered to be structurally related to the parent
Fig. 5. Cross-linking of two vesicles mediated by SP-B. The
positively charged ends of SP-B interact with the head-groups
of the two vesicles and the central parts of SP-B facilitate lipid
transfer by presenting a non-polar surface. The charges of the
Glu51^Arg52 segment are neutralized via formation of hydro-
gen bonds/ion pairs, indicated by the gray area.
Fig. 4. Interactions between SP-B and lipid membranes. Sche-
matic representations of di¡erent ways of locating SP-B in lipid
membranes as deduced from available experimental data and
the structural model of SP-B, see text for details. The SP-B
dimer is represented by the oval symbol, where the positive
signs at the poles symbolize the clusters of mainly basic resi-
dues, the centrally located plus and minus signs represent the
Glu51^Arg52 dipeptide segments, and the central dark area
symbolizes the mainly non-polar central region. (A) SP-B lo-
cated at the edge of a lipid disc, (B) in the super¢cial region of
a membrane or (C) in a transmembraneous manner. In a trans-
membrane orientation, the charges of the Glu51^Arg52 segment
are neutralized via formation of hydrogen bonds/ion pairs, indi-
cated by the gray area.
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molecule as they represent isolated amphipathic heli-
ces of SP-B, or are simpli¢ed or permutated versions
of such helices [32^34]. The present structural model
shows that SP-B exhibits complex features (Fig. 3),
which may be di⁄cult to mimic by single 10^25 res-
idue helical peptides. Some investigations have
yielded signi¢cant e¡ects of such amphipathic or
model peptides on surfactant activity both in vitro
and in vivo [32^34]. In contrast to this, other studies
have shown that single amphipathic helices are inef-
¢cient in promoting lipid spreading and insertion at
an air/water interface, and that a model peptide
based on the N-terminal part of SP-B [33] does not
mimic SP-B in the pulsating bubble surfactometer
[13,35]. An amphipathic model surfactant peptide
[34] e⁄ciently induces lipid disc formation, but is
ine⁄cient in promoting lipid spreading [35]. SP-B
promotes lipid spreading at an air/water interface
[7] and lipid spreading is a central feature of surfac-
tant activity. It therefore seems unlikely that induc-
tion of lipid disc formation is su⁄cient for full activ-
ity of SP analogues. To the best of our knowledge,
none of the previously published SP-B analogues has
been shown to cross-link membranes. The data pre-
sented here indicate that SP-B acts via membrane
cross-linking and that functional SP-B analogues
can be identi¢ed among compounds which lack
structural similarities with SP-B but are capable of
cross-linking lipid membranes.
4. Conclusions
A molecular model of a SP-B dimer shows that
Glu51^Arg52 can form intersubunit hydrogen
bonds/ion pairs and that the overall distribution of
charged and non-polar residues is compatible with
di¡erent locations of SP-B in a lipid bilayer, as well
as with a function of SP-B in membrane cross-link-
ing. The possibility that SP-B may cross-link mem-
branes is supported by showing that polymyxin B,
which is known to cross-link membranes but is struc-
turally di¡erent from SP-B, mimics the activity of
SP-B in a pulsating bubble surfactometer. Further
work is needed to understand the molecular function
of SP-B, and to evaluate the value of polymyxin B,
or other cross-linking/fusogenic compounds, as con-
stituents of arti¢cial surfactants.
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